Volker Möbus
Has participated in:
-
Bevacizumab (Avastin) : effektive zielgerichtete Therapie des HER2-negativen metastasierten Mammakarzinoms
-
Intraductal papilloma without atypia on image-guided breast biopsy: upgrade rates to carcinoma at surgical excision
-
Dose tailoring of adjuvant chemotherapy for breast cancer based on hematologic toxicities: further results from the prospective PANTHER study with focus on obese patients
-
Final results of a phase I/II pilot study of capecitabine with or without vinorelbine after sequential dose-dense epirubicin and paclitaxel in high-risk early breast cancer